Sampre Nutritions Limited has issued a revised intimation correcting the face value for its approved bonus equity issue to ₹5 per share, confirming the 1:1 ratio remains unchanged following the proposed split of equity shares.
The company clarified that the earlier mention of ₹10 face value was inadvertent, and the correct face value for the 1:1 bonus is ₹5 per fully paid share post the proposed split.
The issuance remains one bonus share for every one existing fully paid equity share, aligning the capital structure with the adjusted face value.
Under SEBI Regulation 30 and the 2024 Master Circular, the bonus will be issued from the securities premium account as per audited financials for the year ended March 31, 2025.
The issue size is ₹21,55,68,550 comprising 4,31,13,710 equity shares at ₹5 each, with ₹21,55,68,550 required from reserves.
A balance of ₹59,86,55,263 is available in the securities premium account as on March 31, 2025, sufficient to support the bonus capitalisation.
Bonus shares are targeted to be credited or dispatched on or before November 19, 2025, within 2 months from the board’s approval dated September 19, 2025.
The revised intimation dated September 19, 2025, was addressed to BSE Limited, referencing Scrip Code 530617 and signed digitally by Managing Director Brahma Gurbani.
All other contents of the original outcome filing remain unchanged as per the company’s clarification.
On September 23, 2025, Sampre Nutritions share price opened at ₹109.87 on BSE, above the previous close of ₹107.72.. The stock is trading at ₹109.87, hitting the upper circuit. The stock registered a gain of 2.00%.
Over the past week, it has moved up by 10.40%, over the past month, it has moved up by 51.42%, and over the past 3 months, it has moved up by 252.03%.
Sampre Nutritions confirmed the bonus ratio at 1:1 with the corrected ₹5 face value post the proposed split, detailing audited reserve use, expanded share capital, and an expected credit timeline by November 19, 2025.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Sep 23, 2025, 12:38 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates